{"id":"https://openalex.org/W4361945532","doi":"https://doi.org/10.1158/1078-0432.c.6524379","title":"Data from Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma","display_name":"Data from Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361945532","doi":"https://doi.org/10.1158/1078-0432.c.6524379"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6524379","doi":"https://doi.org/10.1158/1078-0432.c.6524379","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6524379","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6524379","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075692970","display_name":"Jennifer Effie Amengual","orcid":"https://orcid.org/0000-0003-4117-2469","observed_orcids":["https://orcid.org/0000-0003-4117-2469"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer E. Amengual","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012068982","display_name":"Paul M. Johannet","orcid":"https://orcid.org/0000-0002-9264-8327","observed_orcids":["https://orcid.org/0000-0002-9264-8327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Johannet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047947142","display_name":"Maximilian Lombardo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maximilian Lombardo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058238903","display_name":"Kelly M. Zullo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kelly Zullo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040725133","display_name":"Daniela Hoehn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniela Hoehn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014966517","display_name":"Govind Bhagat","orcid":"https://orcid.org/0000-0001-6250-048X","observed_orcids":["https://orcid.org/0000-0001-6250-048X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Govind Bhagat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016848239","display_name":"Luigi Scotto","orcid":"https://orcid.org/0000-0002-7071-926X","observed_orcids":["https://orcid.org/0000-0002-7071-926X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luigi Scotto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025001761","display_name":"Xavier Jirau-Serrano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xavier Jirau-Serrano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071287627","display_name":"Dejan Radeski","orcid":"https://orcid.org/0009-0004-5660-7685","observed_orcids":["https://orcid.org/0009-0004-5660-7685"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dejan Radeski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076260410","display_name":"Jennifer Heinen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Heinen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001737498","display_name":"Hongfeng Jiang","orcid":"https://orcid.org/0000-0002-9261-0433","observed_orcids":["https://orcid.org/0000-0002-9261-0433"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hongfeng Jiang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008043617","display_name":"Serge Cremers","orcid":"https://orcid.org/0000-0002-6800-5532","observed_orcids":["https://orcid.org/0000-0002-6800-5532"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Serge Cremers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Yuan Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuan Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103729912","display_name":"Simon S. Jones","orcid":"https://orcid.org/0009-0008-8557-8536","observed_orcids":["https://orcid.org/0009-0008-8557-8536"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simon Jones","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5002126535","display_name":"Owen A. O\u2019Connor","orcid":"https://orcid.org/0000-0002-5631-0011","observed_orcids":["https://orcid.org/0000-0002-5631-0011"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Owen A. O'Connor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acy-1215","display_name":"ACY-1215","score":0.9459999799728394},{"id":"https://openalex.org/keywords/hdac6-inhibitors","display_name":"HDAC6 inhibitors","score":0.6859999895095825},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.8180000185966492},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9330000281333923},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6859999895095825},{"id":"https://openalex.org/keywords/aggresomes","display_name":"aggresomes","score":0.8579999804496765},{"id":"https://openalex.org/keywords/protein-degradation","display_name":"protein degradation","score":0.7369999885559082},{"id":"https://openalex.org/keywords/unfolded-protein-response","display_name":"unfolded protein response","score":0.9800000190734863},{"id":"https://openalex.org/keywords/grp78","display_name":"GRP78","score":0.8220000267028809},{"id":"https://openalex.org/keywords/xbp1","display_name":"XBP1","score":0.9879999756813049},{"id":"https://openalex.org/keywords/polyubiquitinated-proteins","display_name":"polyubiquitinated proteins","score":0.7789999842643738},{"id":"https://openalex.org/keywords/alpha-tubulin-acetylation","display_name":"alpha-tubulin acetylation","score":0.8320000171661377},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8460000157356262}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.8525303602218628},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6199906468391418},{"id":"https://openalex.org/C23681527","wikidata":"https://www.wikidata.org/wiki/Q18034953","display_name":"HDAC6","level":5,"score":0.5798318982124329},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5514104962348938},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5378180742263794},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.5016803741455078},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.4722019135951996},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47067341208457947},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.459073543548584},{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.4487244486808777},{"id":"https://openalex.org/C187436293","wikidata":"https://www.wikidata.org/wiki/Q4692265","display_name":"Aggresome","level":4,"score":0.4134826958179474},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26641470193862915},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.2640085518360138},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2016792893409729},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.1576443910598755},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.1527249813079834},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15165382623672485},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.13841697573661804},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6524379","doi":"https://doi.org/10.1158/1078-0432.c.6524379","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6524379","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6524379.v1","doi":"https://doi.org/10.1158/1078-0432.c.6524379.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6524379.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6524379","doi":"https://doi.org/10.1158/1078-0432.c.6524379","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6524379","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2113158650","https://openalex.org/W2979615158","https://openalex.org/W2558147844","https://openalex.org/W2546286582","https://openalex.org/W2577944814","https://openalex.org/W3123975871","https://openalex.org/W2606526595","https://openalex.org/W4361945691","https://openalex.org/W2095026025","https://openalex.org/W2562330369"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Pan-class":[2],"histone":[3],"deacetylase":[4,28],"(HDAC)":[5],"inhibitors":[6,15],"are":[7,16,226],"effective":[8],"treatments":[9],"for":[10,37,69,77,111,205,245],"select":[11],"lymphomas.":[12],"Isoform-selective":[13],"HDAC":[14],"emerging":[17],"as":[18,217],"potentially":[19],"more":[20],"targeted":[21],"agents.":[22],"HDAC6":[23,49],"is":[24],"a":[25,199],"class":[26],"IIb":[27],"that":[29,232],"facilitates":[30],"misfolded":[31],"protein":[32,116,236],"transport":[33],"to":[34,98,134,149,230],"the":[35,41,47,114,152,165,173,186,208,227,246],"aggresome":[36,153],"degradation.":[38],"We":[39],"investigated":[40],"mechanism":[42],"and":[43,53,76,86,158,162,193,214,242],"therapeutic":[44],"impact":[45],"of":[46,61,94,105,113,151,164,175,198,201,207,235,248],"selective":[48],"inhibitor":[50],"ACY-1215":[51,70,147],"alone":[52],"in":[54,58,90,100,141,180],"combination":[55,142,187],"with":[56,79,128,143,146,172,185,219],"bortezomib":[57],"preclinical":[59],"models":[60],"lymphoma.":[62,249],"Experimental":[63],"Design:":[64],"Concentration\u2013effect":[65,120],"relationships":[66,121],"were":[67,109,170,178],"defined":[68,122],"across":[71],"16":[72],"lymphoma":[73,107,203],"cell":[74],"lines":[75],"synergy":[78,138],"bortezomib.":[80,144,176],"Mechanism":[81],"was":[82,96,139],"interrogated":[83],"by":[84,155],"immunoblot":[85],"flow":[87],"cytometry.":[88],"An":[89],"vivo":[91,181],"xenograft":[92],"model":[93],"DLBCL":[95],"used":[97],"confirm":[99],"vitro":[101],"findings.":[102],"A":[103],"collection":[104,200],"primary":[106,202],"samples":[108,204],"surveyed":[110],"markers":[112,206],"unfolded":[115],"response":[117],"(UPR).":[118],"Results:":[119],"maximal":[123],"cytotoxicity":[124],"at":[125],"48":[126],"hours":[127],"IC50":[129],"values":[130],"ranging":[131],"from":[132],"0.9":[133],"4.7":[135],"\u03bcmol/L.":[136],"Strong":[137],"observed":[140],"Treatment":[145],"led":[148],"inhibition":[150],"evidenced":[154],"acetylated":[156],"\u03b1-tubulin":[157],"accumulated":[159],"polyubiquitinated":[160],"proteins":[161],"upregulation":[163],"UPR.":[166],"All":[167],"pharmacodynamic":[168],"effects":[169],"enhanced":[171],"addition":[174],"Findings":[177],"validated":[179],"where":[182],"mice":[183],"treated":[184],"demonstrated":[188],"significant":[189],"tumor":[190],"growth":[191],"delay":[192],"prolonged":[194],"overall":[195],"survival.":[196],"Evaluation":[197],"UPR":[209],"revealed":[210],"increased":[211],"HDAC6,":[212],"GRP78,":[213],"XBP-1":[215],"expression":[216],"compared":[218],"reactive":[220],"lymphoid":[221],"tissue.":[222],"Conclusions:":[223],"These":[224],"data":[225],"first":[228],"results":[229],"demonstrate":[231],"dual":[233],"targeting":[234],"degradation":[237],"pathways":[238],"represents":[239],"an":[240],"innovative":[241],"rational":[243],"approach":[244],"treatment":[247],"Clin":[250],"Cancer":[251],"Res;":[252],"21(20);":[253],"4663\u201375.":[254],"\u00a92015":[255],"AACR.":[256]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}